Accrediting bodies see the same mistakes—over and over again. 

But in 2025, this doesn't have to be you. ACHC, URAC, NABP and NCODA see frequent pitfalls like:

• Missing proof of welcome packet delivery
• Gaps in primary source verifications
• Narrow drug utilization reviews
• Incomplete patient profiles
• And more…

Each accrediting body emphasizes different areas, but the shared theme is clear: detailed documentation, tailored processes, and adherence to standards matter more than ever. Streamlining your compliance and accreditation processes can be the difference between just passing or not. A single, holistic solution that consolidates tasks, reduces errors, and keeps you audit-ready is the key to success.

In 2025, don't let compliance management deficiencies hold you back from accreditation or reaccreditation. Read more below on what ACHC, URAC, NABP and NCODA said their top accreditation pitfalls were—and how to avoid them.

Getting accredited or re-accredited in 2025? D2 can help.

If you're preparing for accreditation or reaccreditation, D2's AccredComply platform simplifies accreditation tasks and processes by consolidating all of your compliance needs into one system. With a 100% success rate, D2’s pharmacist-designed compliance solutions can help leaders like you reduce operational burdens, get accredited and scale successfully.